Inventor · disambiguated record
Timothy A. Chan
Also filed as: CHAN TIMOTHY · CHAN TIMOTHY A
6 granted patents·8 pending applications·112 citations·filing 1997–2022
80Inventor score
Files withMEMORIAL SLOAN KETTERING CANCER CENTER10CHAN TIMOTHY1ICAHN SCHOOL MED MOUNT SINAI1INTREXON CORP1UNIV JOHNS HOPKINS1
Top patents by PatentIndex Score
14 records- 0189US5874235AScreening assays for cancer chemopreventative agentsUNIV JOHNS HOPKINS·Filed 1997·Granted Feb 23, 1999·102 cites·28 claims
- 0282US10993998B2Determinants of cancer response to immunotherapy by PD-1 blockadeMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Granted May 4, 2021·3 cites·18 claims
- 0378US11230599B2Tumor mutational loadMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2018·Granted Jan 25, 2022·5 cites·16 claims
- 0469US11332530B2Determinants of cancer response to immunotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2017·Granted May 17, 2022·1 cites·7 claims
- 0567US12331359B2Neoantigens and uses thereof for treating cancerICAHN SCHOOL MED MOUNT SINAI·Filed 2018·Granted Jun 17, 2025·1 cites·21 claims
- 0665US12485162B2Determinants of cancer response to immunotherapy by pd-1 blockadeMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Granted Dec 2, 2025·0 cites·8 claims
- 0758US2023002490A1Determinants of cancer response to immunotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Application pending·0 cites
- 0855US2022340663A1Tumor mutational loadMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Application pending·0 cites
- 0953US2024282410A1Methods for predicting immune checkpoint blockade efficacy across multiple cancer typesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Application pending·0 cites
- 1051US2016326597A1Determinants of cancer response to immunotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2014·Application pending·0 cites
- 1150US2018291074A1Determinants of cancer response to immunotherapy by pd-1 blockadeMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2015·Application pending·0 cites
- 1245US2014113286A1Epigenomic Markers of Cancer MetastasisCHAN TIMOTHY·Filed 2011·Application pending·0 cites
- 1345US2022389102A1Hla class i sequence divergence and cancer therapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Application pending·0 cites
- 1437US2019062394A1Improved Therapeutic Control of Proteolytically Sensitive, Destabilized Forms of Interleukin-12INTREXON CORP·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Timothy A. Chan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →